diltiazem has been researched along with Thrombosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, T; Song, EJ; Tang, S; Wang, J; Zhou, W; Zhu, Z | 1 |
| Burbury, KL; Dobie, G; Grigg, AP; Hamadi, A; Jackson, DE; Kwa, FA; Schwarer, AP | 1 |
| Doi, H; Kaburaki, M; Murata, S; Narita, H; Yasoshima, A | 1 |
| Beaughard, M; Brasset, M; John, G; Massingham, R | 1 |
| Doi, H; Kaburaki, M; Murata, S; Narita, H; Odawara, A; Yasoshima, A | 1 |
| Kauffmann, G; Nöldge, G; Seemann, WR; Wenz, W | 1 |
| Ortega, MP; Priego, JG; Statkow, PR; Sunkel, C | 1 |
7 other study(ies) available for diltiazem and Thrombosis
| Article | Year |
|---|---|
A rare cause of abdominal pain managed unconventionally: acute renal infarction caused by atrial fibrillation: a case report.
Topics: Abdominal Pain; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Diltiazem; Humans; Infarction; Male; Nitroglycerin; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin | 2022 |
Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Cells, Cultured; Cytokines; Diltiazem; Drug-Related Side Effects and Adverse Reactions; Humans; Imidazoles; Inflammation; Inflammation Mediators; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred C57BL; Microfluidics; Platelet Activation; Protein Kinase Inhibitors; Pyridazines; Thrombosis | 2019 |
Antithrombotic effect of TA-993, a novel 1,5-benzothiazepine derivative, in conscious rats.
Topics: Administration, Oral; Animals; Antithrombins; Aspirin; Diltiazem; Dose-Response Relationship, Drug; Embolism; Male; Microscopy, Electron; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombosis; Ticlopidine; Time Factors | 1995 |
Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
Topics: Animals; Aspirin; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Diltiazem; Disease Models, Animal; Dogs; Endothelium, Vascular; Female; Heart Block; Infusions, Intravenous; Ketanserin; Male; Nifedipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Vasodilator Agents; Verapamil | 1995 |
Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis.
Topics: Animals; Antithrombins; Diltiazem; Disease Models, Animal; Dogs; Duodenum; Electric Stimulation; Female; Femoral Artery; Male; Microscopy, Electron, Scanning; Platelet Aggregation Inhibitors; Regional Blood Flow; Thrombosis | 1998 |
[Occlusive and nonocclusive mesenteric ischemia: radiologic aspects].
Topics: Angioplasty, Balloon; Arteriosclerosis; Constriction, Pathologic; Digitalis Glycosides; Diltiazem; Embolism; Humans; Intestines; Ischemia; Mesenteric Arteries; Mesenteric Vascular Occlusion; Radiography; Thrombosis | 1986 |
The antithrombogenic in vivo effects of calcium channel blockers in experimental thrombosis in mice.
Topics: Animals; Calcium Channel Blockers; Collagen; Dihydropyridines; Diltiazem; Disease Models, Animal; Dose-Response Relationship, Drug; Epinephrine; Male; Mice; Mice, Inbred Strains; Nifedipine; Thrombosis; Time Factors; Verapamil | 1987 |